IL148598A - Multifunctional complex for targeting specific phagocytosis of a target agent and a composition comprising it - Google Patents

Multifunctional complex for targeting specific phagocytosis of a target agent and a composition comprising it

Info

Publication number
IL148598A
IL148598A IL148598A IL14859802A IL148598A IL 148598 A IL148598 A IL 148598A IL 148598 A IL148598 A IL 148598A IL 14859802 A IL14859802 A IL 14859802A IL 148598 A IL148598 A IL 148598A
Authority
IL
Israel
Prior art keywords
component
targeting
agent
bacteria
mastitis
Prior art date
Application number
IL148598A
Other languages
English (en)
Other versions
IL148598A0 (en
Inventor
Ely Morag
Jacob Pitkovski
Yosef Pinchasov
Original Assignee
Ely Morag
Yamit Biotechnologies Ltd
Jacob Pitkovski
Yosef Pinchasov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ely Morag, Yamit Biotechnologies Ltd, Jacob Pitkovski, Yosef Pinchasov filed Critical Ely Morag
Priority to IL148598A priority Critical patent/IL148598A/en
Publication of IL148598A0 publication Critical patent/IL148598A0/xx
Priority to JP2003574686A priority patent/JP2006504619A/ja
Priority to EP03708458A priority patent/EP1485414A2/en
Priority to PCT/IL2003/000196 priority patent/WO2003076471A2/en
Priority to MXPA04008847A priority patent/MXPA04008847A/es
Priority to US10/488,402 priority patent/US20040258664A1/en
Priority to CA002478415A priority patent/CA2478415A1/en
Priority to AU2003212633A priority patent/AU2003212633A1/en
Publication of IL148598A publication Critical patent/IL148598A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1275—Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL148598A 2002-03-10 2002-03-10 Multifunctional complex for targeting specific phagocytosis of a target agent and a composition comprising it IL148598A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IL148598A IL148598A (en) 2002-03-10 2002-03-10 Multifunctional complex for targeting specific phagocytosis of a target agent and a composition comprising it
JP2003574686A JP2006504619A (ja) 2002-03-10 2003-03-10 標的因子の特異的食作用のための多機能複合体
EP03708458A EP1485414A2 (en) 2002-03-10 2003-03-10 A multifunctional complex for targeting specific phagocytosis of a target agent
PCT/IL2003/000196 WO2003076471A2 (en) 2002-03-10 2003-03-10 A multifunctional complex for targeting specific phagocytosis of a target agent
MXPA04008847A MXPA04008847A (es) 2002-03-10 2003-03-10 Complejo multifuncional para dirigir la fagocitosis especifica de un agente objetivo.
US10/488,402 US20040258664A1 (en) 2002-03-10 2003-03-10 Multifunctional complex for targeting specific phagocytosis of a target agent
CA002478415A CA2478415A1 (en) 2002-03-10 2003-03-10 A multifunctional complex for targeting specific phagocytosis of a target agent
AU2003212633A AU2003212633A1 (en) 2002-03-10 2003-03-10 A multifunctional complex for targeting specific phagocytosis of a target agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL148598A IL148598A (en) 2002-03-10 2002-03-10 Multifunctional complex for targeting specific phagocytosis of a target agent and a composition comprising it

Publications (2)

Publication Number Publication Date
IL148598A0 IL148598A0 (en) 2002-09-12
IL148598A true IL148598A (en) 2008-04-13

Family

ID=27799844

Family Applications (1)

Application Number Title Priority Date Filing Date
IL148598A IL148598A (en) 2002-03-10 2002-03-10 Multifunctional complex for targeting specific phagocytosis of a target agent and a composition comprising it

Country Status (8)

Country Link
US (1) US20040258664A1 (enExample)
EP (1) EP1485414A2 (enExample)
JP (1) JP2006504619A (enExample)
AU (1) AU2003212633A1 (enExample)
CA (1) CA2478415A1 (enExample)
IL (1) IL148598A (enExample)
MX (1) MXPA04008847A (enExample)
WO (1) WO2003076471A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2339436A1 (fr) * 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
JPWO2010071237A1 (ja) * 2008-12-19 2012-05-31 株式会社 さいわいメディックス タンパク質架橋固定試薬で固定した微生物を抗原として用いる網羅的抗表面抗体作製法
JP5439127B2 (ja) * 2009-11-13 2014-03-12 株式会社さいわいメディカル 乾癬又はアトピー性皮膚炎治療剤
US8926980B2 (en) * 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins
CN103323585B (zh) * 2013-06-06 2015-07-22 广东海大畜牧兽医研究院有限公司 一种检测鱼类无乳链球菌IgM抗体的ELISA试剂盒及其制备方法
EP3022314B1 (en) 2013-07-15 2021-05-19 President and Fellows of Harvard College Assays for antimicrobial activity and applications thereof
NZ721269A (en) * 2013-12-18 2017-09-29 Asahi Chemical Ind Method for detecting streptococcus bacterium contained in milk
EP3094348B1 (en) 2014-01-14 2025-03-05 AbVacc, Inc. Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins
CN108623680A (zh) * 2017-03-17 2018-10-09 蒙永祥 复合抗体提取物及其制备方法和应用
EP4480961A1 (en) 2023-06-23 2024-12-25 Consejo Superior De Investigaciones Científicas Pathogen trapping systems and related aquacultural uses
EP4570822A1 (en) * 2023-12-15 2025-06-18 Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. Immunizing and/or medical preparation for use in preventing and/or treating inflammatory conditions of cow udder

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01168246A (ja) * 1987-12-24 1989-07-03 Taiyo Kagaku Co Ltd 特異的鶏卵抗体を配合してなる養殖魚用飼料
EP0396116B1 (en) * 1989-05-02 1997-02-05 Abbott Laboratories Covalent attachment of specific binding members to a solid phase
US6030805A (en) * 1989-05-04 2000-02-29 Normark; Staffan Fibronectin binding protein as well as its preparation
JPH0356426A (ja) * 1989-07-24 1991-03-12 Gifu Meneki Kenkyusho:Kk ウシ乳房炎予防および治療用抗体含有材料
US5064645A (en) * 1990-07-27 1991-11-12 Pisciconsult Developpement Inc. Hyperimmune composition for passive immunization of fishes against furunculosis caused by Aeromonas salmonicida
GB9112310D0 (en) * 1991-06-07 1991-07-24 United Kingdom Government Fish vaccine
US5585098A (en) * 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
US5700465A (en) * 1994-01-05 1997-12-23 American Cyanamid Company Bovine serum and bovine IgG as preventives and therapeutives for bovine mastitis
US6143559A (en) * 1996-11-18 2000-11-07 Arch Development Corporation Methods for the production of chicken monoclonal antibodies
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
US20050196755A1 (en) * 2000-11-17 2005-09-08 Maurice Zauderer In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
DE10123505A1 (de) * 2001-05-15 2002-11-28 Wolfgang Bergter Immunkonjugate aus Eidotter-Antikörpern (lgY), deren Konfektionierung und Anwendung in Diagnostik und Therapie

Also Published As

Publication number Publication date
EP1485414A2 (en) 2004-12-15
WO2003076471A3 (en) 2004-01-08
JP2006504619A (ja) 2006-02-09
CA2478415A1 (en) 2003-09-18
IL148598A0 (en) 2002-09-12
US20040258664A1 (en) 2004-12-23
WO2003076471A2 (en) 2003-09-18
AU2003212633A1 (en) 2003-09-22
MXPA04008847A (es) 2005-06-17

Similar Documents

Publication Publication Date Title
Kovacs-Nolan et al. Avian egg antibodies: basic and potential applications
KR101785120B1 (ko) 병적 장애의 치료 및/또는 예방에 이용되는 항-ｌｐｓ 풍부한 면역글로블린 조제물
US6322788B1 (en) Anti-bacterial antibodies and methods of use
CA3103656A1 (en) Antibodies against disease causing agents of poultry and uses thereof
JP2008179634A (ja) グラム陽性細菌のリポタイコ酸に特異的なオプソニン性モノクローナルおよびキメラ抗体
US20040202660A1 (en) Methods and compositions for treatment of immune dysfunction disorders
KR102047784B1 (ko) 송아지 소화기성 질병의 예방 또는 치료용 난황항체 제조방법, 이에 의해 제조된 난황항체 및 이의 용도
EP2500034A1 (en) Therapeutic agent for psoriasis or atopic dermatitis
KR102148503B1 (ko) 돼지 소화기성 질병의 예방 또는 치료용 난황항체 제조방법, 이에 의해 제조된 난황항체 및 이의 용도
US20040258664A1 (en) Multifunctional complex for targeting specific phagocytosis of a target agent
US20170196971A1 (en) Antibody guided vaccines and methods of use for generation of rapid mature immune responses
Barrio et al. Assessment of the opsonic activity of purified bovine sIgA following intramammary immunization of cows with Staphylococcus aureus
Oho et al. Bovine milk antibodies against cell surface protein antigen PAc-glucosyltransferase fusion protein suppress cell adhesion and alter glucan synthesis of Streptococcus mutans
RU2573422C2 (ru) Пептид, полученный из человеческого лактоферрина, для применения в качестве агента, маскирующего антиген
JP2005514053A6 (ja) グラム陽性細菌のリポタイコ酸に特異的なオプソニン性モノクローナルおよびキメラ抗体
US20220031826A1 (en) Vaccine For The Prevention And Treatment Of C. Difficile Infections And The Use Thereof
Daley et al. Lysostaphin: immunogenicity of locally administered recombinant protein used in mastitis therapy
JP2006504619A5 (enExample)
KR102260009B1 (ko) 콜레스테롤 흡수 억제를 통한 비만 예방 또는 치료용 난황항체 제조방법
Kaplin et al. IgY-technologies, birds yolk antibodies.
KR102219100B1 (ko) 항 헬리코박터 파이로리 난황항체 제조방법
US20260035437A1 (en) IgY ANTIBODIES TARGETING MONKEYPOX VIRUS AND METHODS OF USE THEREOF
Dallal et al. Identification and extraction of chicken egg yolk immunoglobulin from egg by polyethylene glycol (PEG) precipitation
Chitra Egg yolk antibodies (IgY) and its therapeutic uses for human and animal health-A review
NZ518638A (en) Hyperimmunising a farm animal followed by administration of antigen to mammary gland to produce antibodies in farm animal milk

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees